FI933476A0 - Amylinmuteiner - Google Patents

Amylinmuteiner

Info

Publication number
FI933476A0
FI933476A0 FI933476A FI933476A FI933476A0 FI 933476 A0 FI933476 A0 FI 933476A0 FI 933476 A FI933476 A FI 933476A FI 933476 A FI933476 A FI 933476A FI 933476 A0 FI933476 A0 FI 933476A0
Authority
FI
Finland
Prior art keywords
insulin action
muscle
suppressing
derivatives
muteins
Prior art date
Application number
FI933476A
Other languages
English (en)
Other versions
FI933476A (fi
Inventor
Glenn Colton Andrews
David Kevin Kreutter
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI933476A0 publication Critical patent/FI933476A0/fi
Publication of FI933476A publication Critical patent/FI933476A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI933476A 1992-08-06 1993-08-05 Amylinmuteiner FI933476A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92678392A 1992-08-06 1992-08-06

Publications (2)

Publication Number Publication Date
FI933476A0 true FI933476A0 (fi) 1993-08-05
FI933476A FI933476A (fi) 1994-02-07

Family

ID=25453715

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933476A FI933476A (fi) 1992-08-06 1993-08-05 Amylinmuteiner

Country Status (9)

Country Link
EP (1) EP0654042B1 (fi)
JP (1) JPH07506114A (fi)
AT (1) ATE171951T1 (fi)
CA (1) CA2141203C (fi)
DE (1) DE69321473T2 (fi)
DK (1) DK0654042T3 (fi)
ES (1) ES2122010T3 (fi)
FI (1) FI933476A (fi)
WO (1) WO1994003491A1 (fi)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
ATE128359T1 (de) * 1988-01-11 1995-10-15 Amylin Pharmaceuticals Inc Behandlung von diabetes mellitus typ 2.

Also Published As

Publication number Publication date
DE69321473D1 (en) 1998-11-12
CA2141203A1 (en) 1994-02-17
JPH07506114A (ja) 1995-07-06
FI933476A (fi) 1994-02-07
CA2141203C (en) 2003-07-08
ES2122010T3 (es) 1998-12-16
EP0654042B1 (en) 1998-10-07
DE69321473T2 (de) 1999-03-04
ATE171951T1 (de) 1998-10-15
WO1994003491A1 (en) 1994-02-17
DK0654042T3 (da) 1999-02-15
EP0654042A1 (en) 1995-05-24

Similar Documents

Publication Publication Date Title
KR930003912A (ko) 울혈성 심장 마비 치료법
SE8502950L (sv) Ny galenisk retardform
EA199800943A1 (ru) Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы
DE69428125D1 (de) Fungizide tetrahydrofurane
ES2060910T3 (es) Peptidos que tienen actividad antagonista de taquiquinina, un procedimiento para su preparacion y composiciones farmaceuticas que los comprenden.
ES8801643A1 (es) Un metodo para producir nuevos derivados del acido ascorbico
IT8123602A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
ATE84045T1 (de) Hemmungsstoffe enkephalinase-b deren herstellung und deren pharmazeutische zusammensetzungen.
RU92016453A (ru) Гидроксамовые кислоты и n-гидроксимочевины, способы их получения, фармацевтическая композиция и способ ингибирования липоксигеназы
DK166323C (da) Griseolsyrederivater og farmaceutiske midler indeholdende disse
IT8123603A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
ATE147625T1 (de) Hydantoin- oder imidazolidintrionderivate zur vorbeugung oder behandlung von niereninsuffizienz
KR890014480A (ko) 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
KR910004557A (ko) 2,4,6-치환 페놀 유도체
ATE171951T1 (de) Amylin muteine
CA2118425A1 (en) Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof
ES8406468A1 (es) Procedimiento para la obtencion de derivados de terc.-butanol sustituidos
ATE50248T1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
DK1058544T3 (da) Inhibition af TNF-aktivitet med præparater, der omfatter heparin og oplöselige TNF-receptorer
EP0339878A3 (en) Propanamine derivatives
ES2038612T3 (es) Compuestos de hidroquinolina, composiciones que los contienen y procedimientos para prepararlas.
SE8702422D0 (sv) Improvements in or relating to fungicides
IT1215340B (it) Derivati di esteri dell'acido immidazol-1-il-carbossilico, procedimenti per la loro preparazione e composizioni fungicide che contengono il derivato come componente attivo.
EP0424538A4 (en) Pyridine derivatives and their salts, and insecticidal/acaricidal agent containing the same as active ingredient